In vivo MRI and its histological correlates in acute adoptive transfer experimental allergic encephalomyelitis: Quantification of inflammation and oedema

Brain

Volumn 119, Issue 1, 1996, Pages 239-248

  Morrissey, Scan P ^a,c   Stodal, Horst ^a   Zettl, Uwe ^a   Simonis, Claudia ^a   Jung, Stefan ^a   Kiefer, Reinhard ^a   Lassmann, Hans ^b   Hartung, Hans Peter ^a   Haase, Axel ^a   Toyka, Klaus V ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b Brain Research Institute   (Austria)

^c UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Blood brain barrier; Experimental allergic encephalomyelitis; Gd DTPA; MRI; Multiple sclerosis

Indexed keywords

PENTETIC ACID;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DNA NICK TRANSLATION; INFLAMMATION; MACROPHAGE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; T LYMPHOCYTE;

ACUTE DISEASE; ALBUMINS; ANIMALS; BLOOD-BRAIN BARRIER; BRAIN EDEMA; CONTRAST MEDIA; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GADOLINIUM DTPA; IMMUNOENZYME TECHNIQUES; IMMUNOTHERAPY, ADOPTIVE; MACROPHAGE ACTIVATION; MACROPHAGES; MAGNETIC RESONANCE IMAGING; ORGANOMETALLIC COMPOUNDS; PENTETIC ACID; RATS; RATS, INBRED LEW; STAINING AND LABELING; T-LYMPHOCYTES;

EID: 13344294370     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/119.1.239     Document Type: Article

References (50)

1. Aicher KP, Dupon JW, White DL, Aukerman SL, Moseley ME, Juster R, et al. Contrast-enhanced magnetic resonance imaging of tumor-bearing mice treated with human recombinant tumor necrosis factor Ct. Cancer Res 1990; 50: 7376-81.
2. Barkhof F, Scheltens P, Frequin STFM, Nauta JJP, Tas MW, Valk J, et al. Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity. Am J Roentgenol 1992; 159: 1041-7.
3. Barnes D, McDonald WI, Tofts PS, Johnson G, Landon DN. Magnetic resonance imaging of experimental cerebral oedema. J Neurol Neurosurg Psychiatry 1986; 49: 1341-7.
4. Barnes D, McDonald WI, Johnson G, Tofts PS, Landon DN. Quantitative nuclear magnetic resonance imaging: characterisation of experimental cerebral oedema. J Neurol Neurosurg and Psychiatry 1987; 50: 125-33.
5. Bastianello S, Pozzilli C, Bernardi S, Bozzao L, Fantozzi LM, Buttinelli C, et al. Serial study of gadolinium-DTPA MRI enhancement in multiple sclerosis. Neurology 1990; 40: 591-5.
6. Capra R, Marciano N, Vignolo LA, Chiesa A, Gasparotti R. Gadolinium-pentetic acid magnetic resonance imaging in patients with relapsing remitting multiple sclerosis [see comments]. Arch Neurol 1992; 49: 687-9. Comment in: Arch Neurol 1992; 49: 685-6. Comment in: Arch Neurol 1993; 50: 569-71.
7. Capra R, Marciano N, Vignolo LA, Chiesa A, Gasparotti R. Gadolinium-pentetic acid magnetic resonance imaging in patients with relapsing remitting multiple sclerosis [see comments]. Arch Neurol 1992; 49: 687-9. Comment in: Arch Neurol 1992; 49: 685-6. Comment in: Arch Neurol 1993; 50: 569-71.
8. Capra R, Marciano N, Vignolo LA, Chiesa A, Gasparotti R. Gadolinium-pentetic acid magnetic resonance imaging in patients with relapsing remitting multiple sclerosis [see comments]. Arch Neurol 1992; 49: 687-9. Comment in: Arch Neurol 1992; 49: 685-6. Comment in: Arch Neurol 1993; 50: 569-71.
9. Damoiseaux JGM, Döpp EA, Calame W, Chao D, MacPherson GG, Dijkstra CD. Rat macrophage lysosomal membrane antigen recognized by monoclonal antibody ED1. Immunology 1994; 83: 140-7.
10. Deichmann R, Haase A. Quantification of T1 values by SNAPSHOT FLASH MR imaging. J Magn Reson 1992; 96: 608-12
11. Ellison MD, Krieg RJ, Povlishock JT. Differential central nervous system responses following single and multiple recombinant interleukin-2 infusions. J Neuroimmunol 1990; 28: 249-60.
12. Fretland DJ. Potential role of prostaglandins and leukotrienes in multiple sclerosis and experimental allergic encephalomyelitis. [Review]. Prostaglandins Leukot Essent Fatty Acids 1992; 45 249-57.
13. Gonzalez-Scarano F, Grossman RI, Galetta S, Atlas SW, Silberberg DH. Multiple sclerosis disease activity correlates with gadolinium-enhanced magnetic resonance imaging. Ann Neurol 1987, 21: 300-6.
14. Grossman RI, Gonzalez-Scarano F, Atlas SW, Galetta S, Silberberg DH. Multiple sclerosis: gadolinium enhancement in MR imaging. Radiology 1986; 161: 721-5.
15. Haase A. Snapshot FLASH MRI. Applications to T1, T2, and chemical-shift maging. Magn Reson Med 1990; 13: 77-89.
16. Harris JO, Frank JA, Patronas NJ, McFarlin DE, McFarland HF. Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: implications for clinical trials and natural history. Ann Neurol 1991; 29: 548-55
17. Hartung H-P, Schäfer B, Heininger K, Stoll G, Toyka KV. The role of macrophages and eicosanoids in the pathogenesis of experimental allergic neuritis. Brain 1988; 111: 1039-59.
18. Hartung H-P, Jung S, Stoll G, Zielasek J, Schmidt B, Archelos JJ, et al. Inflammatory mediators in demyelinating disorders, of the CNS and PNS. [Review]. J Neuroimmunol 1992; 40: 197-210.
19. Hawkins CP, Munro PMG, MacKenzie F, Kesselring J, Tofts PS, du Boulay EPGH, et al. Duration and selectivity of blood-brain bamer breakdown in chronic relapsing experimental allergic encephalomyelitis studied by gadolinium-DTPA and protein markers. Brain 1990; 113: 365-78.
20. Hawkins CP, Mackenzie F, Tofts PS, du Boulay EPGH, McDonald WI. Patterns of blood-brain barrier breakdown in inflammatory demyelination. Brain 1991; 114: 801-10.
21. Hawkins CP, Munro PMG, Landon DN, McDonald WI. Metabolically dependent blood-brain barrier breakdown in chronic relapsing experimental allergic encephalomyelitis. Acta Neuropathol (Berl) 1992; 83: 630-5.
22. Höllerhage HG, Walter GF, Stolke D. Complement-derived polypeptide C3adesArg as a mediator of inflammation at the blood-brain barrier in a new experimental cat model. Acta Neuropathol (Berl) 1989; 77: 307-13.
23. Jung S, Krämer S, Schlüsener HJ, Hünig T, Toyka KV, Hartung H-P. Prevention and therapy of experimental autoimmune neuritis by an antibody against T-cell receptors-α/β. J Immunol 1992; 148: 3768-75.
24. Karlik SJ, Strejan G, Gilbert JJ, Noseworthy JH. NMR studies in experimental allergic encephalomyelitis (EAE): normalization of T1 and T2 with parenchymal cellular infiltration. Neurology 1986; 36: 1112-14.
25. Katz D, Taubenberger JK, Cannella B, McFarlin DE, Raine CS, McFarland HF. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol 1993; 34: 661-9.
26. Kermode AG, Tofts PS, MacManus DG, Kendall BE, Kingsley DPE, Moseley IF, et al. Early lesion of multiple sclerosis [letter]. Lancet 1988; 2: 1203-4.
27. Kermode AG, Tofts PS, Thompson AJ, MacManus DG, Rudge P, Kendall BE, et al. Heterogeneity of blood-brain barrier changes in multiple sclerosis: an MRI study with gadolinium-DTPA enhancement. Neurology 1990; 40: 229-35.
28. Lassmann H. Comparative neuropathology of chronic experimental allergic encephalomyelitis and multiple sclerosis, Berlin: Springer Verlag. 1983.
29. Lassmann H, Brunner C, Bradl M, Linington C. Experimental allergic encephalomyelitis: the balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions. Acta Neuropathol (Berl) 1988; 75: 566-76.
30. Lassmann H, Schmied M, Vass K, Hickey WF. Bone marrow derived elements and resident microglia in brain inflammation. Glia 1993; 7: 19-24.
31. Linington C, Morgan BP, Scolding NJ, Wilkins PB, Piddlesden S, Compston DAS. The role of complement in the pathogenesis of experimental allergic encephalomyelitis. Brain 1989a; 112: 895-911.
32. Linington C, Lassmann H, Morgan BP, Compston DAS. Immunohistochemical localisation of terminal complement component C9 in experimental allergic encephalomyelitis. Acta Neuropathol (Berl) 1989b; 79: 78-85.
33. McFarland HF, Frank JA, Albert PS, Smith ME, Martin R, Harris JO, et al. Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis. Ann Neurol 1992; 32: 758-66.
34. Miller DH, Rudge P, Johnson G, Kendall BE, Macmanus DG, Moseley IF, et al. Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. Brain 1988; 111: 927-39.
35. Namer LJ, Steibel J, Poulet P, Armspach JP, Mauss Y, Chambron J, In vivo dynamic MR imaging of MBP-induced acute experimental allergic encephalomyelits in Lewis rat [published erratum appears in Magn Reson Med 1992; 25: 213-14]. Magn Reson Med 1992; 24: 325-34.
36. Namer IJ, Steibel J, Poulet P, Armspach JP, Mohr M, Mauss Y, et al. Blood-brain barrier breakdown in MBP-specific T-cell induced experimental allergic encephalomyelitis. Brain 1993; 116: 147-59.
37. Nekolla S, Gneiting T, Syha J, Deichmann R, Haase A. T1 maps by K-space reduced snapshot-FLASH MRI. J Comput Assist Tomogr 1992; 16: 327-32.
38. Nesbit GM, Forbes GS, Scheithauer BW, Okazaki H, Rodriguez M. Multiple sclerosis: histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy. Radiology 1991; 180: 467-74.
39. Pellegrino L, Pellegrino AS, Cushman AJ. A stereotaxic atlas of the rat brain. 2nd ed. New York: Plenum Press, 1979.
40. Piddlesden S, Lassmann H, Laffafian I, Morgan BP, Linington C. Antibody-mediated demyelination in experimental allergic encephalomyelitis is independent of complement membrane attack complex formation. Clin Exp Immunol 1991; 83: 245-50.
41. Quagliarello VJ, Wispelwey B, Long WJ Jr, and Scheld WM. Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factor. J Clin Invest 1991; 87(4): 1360-6.
42. Saukkonen K, Sande S, Cioffe C, Wolpe S, Sherry B, Cerami A, et al. The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis. J Exp Med 1990; 171: 439-48.
43. Schmied M, Breitschopf H, Gold R, Zischler H, Rothe G, Wekerle H, et al. Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis. Evidence for programmed cell death as a mechanism to control inflammation in the brain. Am J Pathol 1993; 143: 446-52.
44. Scolding NJ, Morgan BP, Houston WAJ, Linington C, Campbell AK, Compston DAS. Vesicular removal by oligodendrocytes of membrane attack complexes formed by activated complement. Nature 1989; 339: 620-2.
45. Seeldrayers PA, Syha J, Morrissey SP, Stodal H, Vass K, Jung S, et al. Magnetic resonance imaging investigation of blood-brain barrier damage in adoptive transfer experimental autoimmune encephalomyelitis. J Neuroimmunol 1993; 46: 199-206.
46. Seitz RJ, Heiniger K, Schwendemann G, Toyka KV. Application of the avidin-biotin system for the post-embedding cytochemical demonstration of a biotin-labeled IgG tracer. J Histochem Cytochem 1986; 34: 547-9.
47. Sharief MK, Noori MA, Ciardi M, Cirelli A, Thompson EJ. Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis. Correlation with TNF-α and blood-brain barrier damage. J Neuroimmunol 1993; 43; 15-22.
48. Thompson AJ, Kermode AG, Wicks D, MacManus DG, Kendall BE, Kingsley DPE, et al. Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann Neurol 1991; 29: 53-62.
49. Thorpe JW, Miller DH. MRI: its application and impact. [Review]. Int MSJ 1994; 1: 7-15.
50. Zoukos Y, Kidd D, Woodroofe MN, Kendall BE, Thompson AJ, Cuzner ML. Increased expression of high affinity IL-2 receptors and β-adrenoreceptors on peripheral blood mononuclear cells is associated with clinical and MRI activity in multiple sclerosis. Brain 1994; 117: 307-15.